Do men die young and sick, or do women live long and healthy? By trying to explain the
sexual dimorphism in life expectancy, both biological and environmental aspects are …

In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccines were licensed and recommended for use in adults and adolescents in the United …

The prevalence of many chronic diseases has increased over the last decades. It has been
postulated that dysbiosis driven by environmental factors such as antibiotic use is shifting …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

Current Medical Diagnosis and Treatment 2012 Page 1 Current Medical Diagnosis and
Treatment 2012 McPhee, Stephen J. MD ISBN-13: 9780071763721 Table of Contents Table of …

Objective To examine immunization responses in patients with rheumatoid arthritis (RA)
treated with rituximab and to investigate the effects of rituximab‐induced CD20+ B cell …

Background The impact of dupilumab, an anti–interleukin (IL) 4 receptor α antibody that
inhibits IL-4 and IL-13 signaling, on vaccine responses of patients with atopic dermatitis (AD) …

During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis
vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in …

Summary On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …

Pertussis is resurgent in some countries, particularly those in which children receive
acellular pertussis (aP) vaccines in early infancy and boosters later in life. Immunologic …